NexgenRx Inc. (TSXV:NXG)
Canada · Delayed Price · Currency is CAD 0.6000
0.00 (0.00%)
Aug 7, 2026, 1:08 PM EST
NexgenRx Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 43 | 28 | 20 | 16 | 19 | 28 | |
Market Cap Growth | 71.43% | 43.23% | 27.99% | -18.29% | -32.50% | 67.66% |
Enterprise Value | 39.95 | 25.69 | 20.34 | 15.75 | 19.31 | 27.87 |
Last Close Price | 0.60 | 0.40 | 0.28 | 0.22 | 0.27 | 0.40 |
PE Ratio | 25.00 | 28.57 | 56.00 | - | - | 7.41 |
PS Ratio | 2.31 | 1.59 | 1.21 | 1.12 | 1.49 | 2.38 |
PB Ratio | 4.84 | 3.73 | 2.61 | 2.01 | 2.15 | 2.90 |
P/TBV Ratio | 7.11 | 5.99 | 5.28 | 4.67 | 5.41 | 8.92 |
P/FCF Ratio | 9.65 | 6.08 | 18.66 | 12.93 | 28.04 | 7.61 |
P/OCF Ratio | 9.11 | 5.72 | 17.27 | 12.15 | 17.81 | 7.36 |
EV/Sales Ratio | 2.17 | 1.43 | 1.23 | 1.14 | 1.51 | 2.35 |
EV/EBITDA Ratio | 10.18 | 8.07 | 8.75 | 15.27 | 12.36 | 8.20 |
EV/EBIT Ratio | 14.35 | 13.09 | 19.23 | - | 123.29 | 13.49 |
EV/FCF Ratio | 9.03 | 5.49 | 19.11 | 13.12 | 28.51 | 7.54 |
Debt / Equity Ratio | 0.03 | 0.04 | 0.06 | 0.05 | 0.04 | 0.02 |
Debt / EBITDA Ratio | 0.09 | 0.12 | 0.23 | 0.45 | 0.28 | 0.12 |
Debt / FCF Ratio | 0.08 | 0.08 | 0.50 | 0.39 | 0.64 | 0.11 |
Net Debt / Equity Ratio | -0.49 | -0.58 | -0.15 | -0.18 | -0.15 | -0.20 |
Net Debt / EBITDA Ratio | -1.11 | -1.38 | -0.50 | -1.37 | -0.85 | -0.56 |
Net Debt / FCF Ratio | -0.99 | -0.94 | -1.10 | -1.18 | -1.97 | -0.52 |
Asset Turnover | 0.47 | 0.53 | 0.54 | 0.50 | 0.46 | 0.43 |
Quick Ratio | 0.18 | 0.19 | 0.12 | 0.12 | 0.13 | 0.14 |
Current Ratio | 1.16 | 1.13 | 1.10 | 1.06 | 1.09 | 1.07 |
Return on Equity (ROE) | 26.26% | 16.92% | 8.01% | -4.01% | -0.24% | 52.75% |
Return on Assets (ROA) | 5.55% | 3.90% | 2.09% | -1.07% | -0.09% | 15.10% |
Return on Invested Capital (ROIC) | 56.15% | 27.07% | 9.93% | -4.35% | -0.34% | 59.14% |
Return on Capital Employed (ROCE) | 32.75% | 24.59% | 13.08% | -3.18% | 1.64% | 25.61% |
Earnings Yield | 4.12% | 3.50% | 1.79% | - | 0.00% | 13.50% |
FCF Yield | 10.36% | 16.45% | 5.36% | 7.74% | 3.57% | 13.14% |
Dividend Yield | 2.50% | 3.75% | 3.58% | 4.54% | 3.70% | 0.00% |
Payout Ratio | 65.19% | 82.71% | 115.56% | -212.17% | -3139.85% | 0.00% |
Buyback Yield / Dilution | 0.51% | -0.68% | -8.51% | -0.28% | 6.01% | -0.88% |
Total Shareholder Return | 3.01% | 3.07% | -4.93% | 4.26% | 9.72% | -0.88% |